Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Agency

All agencies FDA (Food)FDA (Drugs)FDA (Devices)USDA FSIS CPSC NHTSA EPA

3701–3725 of 18005

HighFDA (Drugs)·D-1276-2022·2022-07-27
Nephron Phenylephrine HCl Injection Recalled for Lack of Sterility Assurance
Nephron Sterile Compounding Center LLC recalls Phenylephrine HCl Injection (1 mg/10 mL) syringes nationwide due to inability to guarantee sterility. Approximately 464,265 syringes across eleven lot numbers are affected.
Product
Phenylephrine HCl Injection, USP, 1 mg/10 mL (100 mcg/mL) syringe, packaged in 5 x 10 mL Pre-Filled Syringes per carton, 6 x 5 Syringe Carton per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-957-10
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-1268-2022·2022-07-27
Morphine Sulfate Injection Recalled Due to Sterility Assurance Concerns
Nephron Sterile Compounding Center LLC is recalling morphine sulfate injection syringes due to lack of assurance of sterility. The recall affects 4,620 pre-filled syringes distributed nationwide.
Product
Morphine Sulfate Injection, USP, 1 mg/mL syringe, packaged in 5 x 1 mL Pre-Filled Syringes per carton, 6 x 5 Syringe Carton per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-979-01
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-1258-2022·2022-07-27
FDA Recalls HYDROmorphone Injection Syringes Due to Sterility Concerns
Nephron Sterile Compounding Center is recalling 3,740 HYDROmorphone injection syringes due to lack of assurance of sterility. The affected lot was distributed nationwide.
Product
HYDROmorphone HCl Injection, USP, 50 mg/50 mL (1 mg/mL) syringes, packaged in 5 x 50 mL Pre-Filled Syringes per carton, 6 x 5 Syringe Carton per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-559-50
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-1282-2022·2022-07-27
Aspirin-Dipyridamole Capsules Recalled for Capsule Breakage Defect
Glenmark Pharmaceuticals is recalling Aspirin and Extended-Release Dipyridamole Capsules due to capsule breakage defects. Approximately 168,936 bottles were distributed nationwide.
Product
ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE — ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE (ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE)
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-1340-2022·2022-07-27
FDA Recalls Launch Sequence Euphoria Capsules as Unapproved Drug
Launch Sequence Euphoria Capsules were marketed without FDA approval. Consumers should discontinue use immediately and contact the manufacturer.
Product
Launch Sequence Euphoria Capsules, 10- count tins, ASIN B08ZJX4V9J, UPC Code 661020846864.
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-1244-2022·2022-07-27
OTC Hydrogen Peroxide Solution Recalled for Isopropyl Alcohol Contamination
Vi-Jon's hydrogen peroxide topical solution has been recalled due to cross-contamination with low levels of isopropyl alcohol. Multiple brands are affected nationwide in the USA and Canada.
Product
HYDROGEN PEROXIDE — HYDROGEN PEROXIDE (HYDROGEN PEROXIDE)
Category
Drug
Distribution
Distributed nationwide
CriticalFDA (Drugs)·D-1188-2022·2022-07-20
Morphine Sulfate Extended-Release Tablets Recalled for Strength Label Mix-up
Bryant Ranch Prepack has recalled Morphine Sulfate extended-release tablets due to a label mix-up where bottles may contain the wrong strength. Contact your pharmacy to verify your correct dose.
Product
Morphine Sulfate extended-Release Tablets, USP; 60 mg, 100-count bottles, Rx only, manufactured by: Ohm Laboratories Inc., NJ; Relabeled by: Bryant Ranch Prepack, Inc, CA, NDC 63629-1089-01
Category
Drug
Distribution
1 state
SevereFDA (Drugs)·D-1284-2022·2022-07-20
Arti King tablets recalled for undeclared pharmaceutical ingredients
Arti King Refozado con Ortiga y Omega 3 Tablets are recalled nationwide because FDA testing found undeclared diclofenac and dexamethasone. The product was marketed without FDA approval and should not be used.
Product
Arti King Refozado con Ortiga y Omega 3 Tablets, 100-count bottles, Hecho en Mexico por: "PLANTAS MEDICINALES DE MEXICO", Melchor Ocampo No. 55 Local D, Delegacion Xochimilco, C.P. 16800 Mexico, UPC 7 501031 111138
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1187-2022·2022-07-20
Morphine Sulfate Tablets Recalled for Label Mix-up Dosage Error
Morphine Sulfate extended-release tablets (30 mg) distributed in Alabama were recalled due to a critical label mix-up where bottles labeled as 60 mg contain 30 mg, and bottles labeled as 30 mg may contain 60 mg.
Product
Morphine Sulfate extended-Release Tablets, USP; 30 mg, 100-count bottles, Rx only, manufactured by: Ohm Laboratories Inc., New Brunswick NJ 08901 USA; Relabeled by: Bryant Ranch Prepack, Inc., Burbank, CA, 91504 USA, NDC: 63629-1088-01.
Category
Drug
Distribution
1 state
HighFDA (Drugs)·D-1204-2022·2022-07-20
Compounded Injectable Amino Acid Drug Recalled for Sterility Assurance Issues
Tailor Made Compounding is recalling 60 GOAL injectable vials nationwide due to lack of sterility assurance, which may pose a contamination risk.
Product
GOAL (Glutamine/Ornithine/Arginine/Lysine 25mg/75mg/150mg/250mg/ml) 30 ml-vial, Refrigerate, Tailor Made Compounding
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-1239-2022·2022-07-20
Testosterone Propionate Injectable Vials Recalled Over Sterility Assurance
Testosterone propionate injectable vials are being recalled due to lack of assurance of sterility. The recall affects product distributed nationwide in the USA and Puerto Rico.
Product
Testosterone Propionate 100mg/ml, 10mL-vial, Room temperature, Tailor Made Compounding
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-1233-2022·2022-07-20
Compounded Testosterone/Anastrozole Injectable Vials Recalled for Sterility Assurance
Tailor Made Compounding is recalling 106 vials of compounded testosterone/anastrozole injectable due to lack of sterility assurance. The product was distributed nationwide in the USA and Puerto Rico.
Product
Testosterone Cypionate/Anastrozole 200mg/1mg/mL, a) 4 mL-vial, b)10mL-vial, Room temperature, Tailor Made Compounding
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-1223-2022·2022-07-20
PT-141 10mg/mL Injectable Vials Recalled for Sterility Assurance Concerns
Tailor Made Compounding is recalling PT-141 10mg/mL vials nationwide due to inability to assure sterility. The recall affects 392 vials in 1mL and 2mL sizes distributed in 2022.
Product
PT-141 10mg/mL a) 1mL-vial, b) 2 mL-vial, Refrigerate, Tailor Made Compounding
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-1210-2022·2022-07-20
Compounded injectable product recalled for lack of sterility assurance
Tailor Made Compounding is recalling 25 vials of a compounded injectable product due to lack of assurance of sterility. The affected batches were distributed nationwide.
Product
Inositol/Choline B12 + Carnitine 40mg/40mg/1mg/100mg/mL, 30mL-vial, Refrigerate, Tailor Made Compounding
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-1199-2022·2022-07-20
Dexpanthenol injectable vials recalled for lack of sterility assurance
Tailor Made Compounding is recalling 19 vials of Dexpanthenol 250mg/mL due to lack of assurance of sterility. Two batches with different expiration dates were distributed nationwide in the USA and Puerto Rico.
Product
Dexpanthenol 250mg/mL, 30mL-vial, Room Temperature, Tailor Made Compounding
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-1222-2022·2022-07-20
Procaine HCL Injectable Recalled Due to Sterility Assurance Concerns
Tailor Made Compounding is recalling Procaine HCL 2% injectable solution due to lack of sterility assurance. The recall affects 58 vials distributed nationwide.
Product
Procaine HCL 2% (20mg/mL), 30 ml-vial, Refrigerate, Tailor Made Compounding
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-1226-2022·2022-07-20
Sermorelin Recalled Due to Lack of Sterility Assurance
Tailor Made Compounding is recalling 1,208 vials of Sermorelin due to inability to assure sterility. The product was distributed nationwide in the USA and Puerto Rico across multiple batch lots.
Product
Sermorelin 2000mcg/mL, 7.5mL-vial, Refrigerate, Tailor Made Compounding
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-1217-2022·2022-07-20
Methylcobalamin Injectable Recalled Due to Lack of Sterility Assurance
Tailor Made Compounding is recalling Methylcobalamin Preservative Free 10mg/mL injectable due to lack of assurance of sterility. The affected batch may not meet sterility standards required for injectable medications.
Product
Methylcobalamin Preservative Free, 10mg/mL, 1mL-vial, Room Temperature, Tailor Made Compounding
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-1196-2022·2022-07-20
BCAA Injection Vials Recalled for Lack of Sterility Assurance
Tailor Made Compounding is recalling 180 vials of BCAA (branched-chain amino acid) injections nationwide due to inability to assure the product maintained sterility. Affected batches expire between April and June 2022.
Product
BCAAs (Leucine/Iso-Leucine/Valine) 10mg/10mg/5mg/mL, 30mL-vial, Refrigerate, Tailor Made Compounding
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-1238-2022·2022-07-20
Compounded Testosterone Enanthate Injectables Recalled for Lack of Sterility Assurance
Tailor Made Compounding is recalling 414 vials of Testosterone Enanthate 200mg/ml (5 mL and 10 mL) due to lack of assurance of sterility. The product was distributed nationwide in the USA and Puerto Rico.
Product
Testosterone Enanthate (GSO) 200mg/ml, a) 5 mL-vial, b) 10 mL-vial, Room temperature, Tailor Made Compounding
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-1219-2022·2022-07-20
NAD+ Injectable Vials Recalled Due to Lack of Sterility Assurance
Tailor Made Compounding is recalling 1,856 vials of NAD+ 200mg/mL because the company cannot assure the product meets sterility requirements. The affected vials were distributed nationwide to the United States and Puerto Rico.
Product
NAD+ 200mg/mL, 10mL-vial, Refrigerate, Tailor Made Compounding
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-1198-2022·2022-07-20
Calcium Chloride Injectable Solution Recalled Due to Sterility Assurance Concerns
TMC Acquisition LLC is recalling Calcium Chloride Preservative Free injectable solution in 5 mL and 30 mL vials due to lack of assurance of sterility. The recall affects 138 vials distributed nationwide.
Product
Calcium Chloride Preservative Free, 100mg/mL, a) 5 mL-vial, b) 30 ml-vial, Room Temperature, Tailor Made Compounding
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-1191-2022·2022-07-20
CVS Hydrogen Peroxide Bottles Contain Isopropyl Alcohol Due to Label Mix-Up
CVS Hydrogen Peroxide Topical Solution bottles contain 70% isopropyl alcohol instead of the labeled hydrogen peroxide. The labeling error could lead to misuse and potential harm if consumers use the product as labeled.
Product
HYDROGEN PEROXIDE — HYDROGEN PEROXIDE (HYDROGEN PEROXIDE)
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-1190-2022·2022-07-20
Testosterone Cypionate Injection Recalled for Water Leakage in Manufacturing
Sun Pharmaceutical recalls 50,860 vials of Testosterone Cypionate Injection due to water leakage during manufacturing that could affect product sterility. The firm-initiated recall was reported in July 2022 and affects nationwide distribution.
Product
TESTOSTERONE CYPIONATE — TESTOSTERONE CYPIONATE (TESTOSTERONE CYPIONATE)
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-1237-2022·2022-07-20
FDA Recalls Compounded Testosterone Injection for Sterility Assurance
Tailor Made Compounding is recalling 93 vials of Testosterone Enanthate due to lack of assurance of sterility. The affected batches were distributed nationwide and in Puerto Rico.
Product
Testosterone Enanthate (GSO) 100mg/ml, 2 mL-vial, Room temperature, Tailor Made Compounding
Category
Drug
Distribution
Distributed nationwide

How to read this listing

Filters

3701–3725 of 18005